To read more on this topic click here.
Researchers present in-depth review of 145 clinical trials for Parkinson’s
Author: Sophie BatesPublished: 27 August 2020
Prep: Cook: Serves:
A recent report conducted by researchers at The Cure Parkinson’s Trust and research advocates, presents an in-depth review of current clinical trials that are targeting Parkinson’s.
With the global number of people living with Parkinson’s expected to double by 2040, the objective of the investigation was to increase awareness of clinical trials and create opportunities for collaboration between the research community and people with the condition.
As part of the review – published in the Journal of Parkinson’s Disease – researchers categorised 145 trials into the type of drug being tested and the stage of their clinical development, to highlight trends in how the condition is being targeted.
Parkinson’s research advocate Dr Kevin McFarthing, said: “The number of clinical trials under way is encouraging for the Parkinson’s community, especially the high proportion of repurposed initiatives that increase the chances of a new therapy becoming available quickly.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Share this story
Young onset Parkinson’s: “How I look is not how I feel”
The first in our series profiling Parkinson's Vision 2020 speakersREAD MORE
Pro cyclist to non-profit founder: Davis Phinney on life with Parkinson’s
The Tour de France stage winner talks about living well with Parkinson’sREAD MORE
Save the last dance for Google Glass
How innovative software is helping patients dance off symptomsREAD MORE